会员体验
专利管家(专利管理)
工作空间(专利管理)
风险监控(情报监控)
数据分析(专利分析)
侵权分析(诉讼无效)
联系我们
交流群
官方交流:
QQ群: 891211   
微信请扫码    >>>
现在联系顾问~
热词
    • 7. 发明申请
    • ANTIBODIES TO MYOSTATIN
    • 肌肉蛋白抗体
    • WO2006116269A3
    • 2007-03-01
    • PCT/US2006015407
    • 2006-04-24
    • PFIZERAMGEN FREMONT INCCHIN EVA ROSEIBEBUNJO CHIKWENDUKRASNEY PHILIP ALBERTYIE JUNMINGZACHWIEJA JOSEPHGREEN LARRY
    • CHIN EVA ROSEIBEBUNJO CHIKWENDUKRASNEY PHILIP ALBERTYIE JUNMINGZACHWIEJA JOSEPHGREEN LARRY
    • A61K38/17C07K14/705
    • C07K16/22A61K2039/505C07K2317/21C07K2317/33C07K2317/34C07K2317/56C07K2317/76
    • The present invention relates to antibodies including human antibodies and antigen-binding portions thereof that bind to myostatin, and that function to inhibit myostatin. The invention also relates to human anti-myostatin antibodies and antigen-binding portions thereof. The invention also relates to antibodies that are chimeric, bispecific, derivatized, single chain antibodies or portions of fusion proteins. The invention also relates to isolated heavy and light chain immunoglobulins derived from human anti-myostatin antibodies and nucleic acid molecules encoding such immunoglobulins. The present invention also relates to methods of making human anti-myostatin antibodies, compositions comprising these antibodies and methods of using the antibodies and compositions for diagnosis and treatment. The invention also provides gene therapy methods using nucleic acid molecules encoding the heavy and/or light immunoglobulin molecules that comprise the human anti-myostatin antibodies. The invention also relates to transgenic animals or plants comprising nucleic acid molecules of the present invention.
    • 本发明涉及结合肌生成抑制素的抗体,包括人抗体及其抗原结合部分,并且其功能是抑制肌生成抑制素。 本发明还涉及人抗肌生成抑制素抗体及其抗原结合部分。 本发明还涉及嵌合,双特异性,衍生的单链抗体或融合蛋白的部分的抗体。 本发明还涉及衍生自人抗肌生成抑制素抗体的分离的重链和轻链免疫球蛋白和编码这种免疫球蛋白的核酸分子。 本发明还涉及制备人抗肌生成抑制素抗体的方法,包含这些抗体的组合物和使用抗体和组合物进行诊断和治疗的方法。 本发明还提供使用编码包含人抗肌生成抑制素抗体的重和/或轻免疫球蛋白分子的核酸分子的基因治疗方法。 本发明还涉及包含本发明的核酸分子的转基因动物或植物。